HIVE:NASDAQHIVE Digital Technologies Ltd Analysis
Data as of 2026-06-11 - not real-time
$3.50
Latest Price
8/10Risk
Risk Level: High
Executive Summary
HIVE Digital Technologies trades at $3.50, below its 20‑day SMA of $3.88 but above the 50‑day ($2.99) and 200‑day ($3.28) averages, indicating short‑term weakness amid a neutral longer‑term trend. The RSI of 47 and a bearish MACD histogram suggest limited upside momentum in the near term, while volume is on a decreasing trend and 30‑day volatility exceeds 120%, underscoring a highly erratic price pattern. Fundamentally, the company posted a 158% revenue jump in fiscal 2026, delivering $257 M in sales with a 38.5% gross margin and strong operating cash flow of $97 M, generating free cash flow of $96 M. However, operating and net margins remain deeply negative (‑54% and ‑48% respectively) and leverage is elevated, with a debt‑to‑equity ratio above 3. Analyst sentiment is very positive – a “strong buy” consensus and a median target price of $7.00, implying roughly 100% upside from current levels. The DCF fair‑value estimate of $12.92 and the “Extreme Greed” market sentiment further highlight a potential disconnect between price and intrinsic value. Recent news of a strategic focus on AI‑driven high‑performance computing and a projected $660 M ARR reinforce the growth narrative, but regulatory uncertainty around crypto mining and the company’s high beta (≈3.6) keep risk elevated.
Given the stark contrast between the bearish short‑term technical signals and the compelling long‑term fundamentals, investors should weigh the substantial upside potential against the pronounced volatility, leverage, and sector‑specific regulatory headwinds.
Given the stark contrast between the bearish short‑term technical signals and the compelling long‑term fundamentals, investors should weigh the substantial upside potential against the pronounced volatility, leverage, and sector‑specific regulatory headwinds.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 6/10
Key Factors
- Bearish MACD and decreasing volume suggest caution
- Analyst strong‑buy consensus and near‑term price support
- High volatility may create short‑term entry opportunities
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust 158% revenue growth and positive free cash flow
- Undervaluation relative to DCF fair value and analyst targets
- Strategic shift toward AI and high‑performance computing
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term upside from green data‑center footprint and crypto adoption
- Significant upside potential versus current market price
- Risk mitigated by strong cash position despite high leverage
Key Metrics & Analysis
Financial Health
Revenue Growth218.60%
Profit Margin-48.63%
P/E Ratio14.6
ROE-25.17%
ROA-10.78%
Debt/Equity3.23
P/B Ratio1.5
Op. Cash Flow$97.2M
Free Cash Flow$96.3M
Industry P/E16.5
Technical Analysis
TrendNeutral
RSI47.2
Support$2.68
Resistance$5.02
MA 20$3.88
MA 50$2.99
MA 200$3.28
MACDBearish
VolumeDecreasing
Fear & Greed Index84.39
Valuation
Fair Value$12.92
Target Price$6.93
Upside/Downside97.96%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta3.65
Volatility123.19%
Sector RiskHigh
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.